Bukwang Pharm (003000) — Net Asset Quality Index
Bukwang Pharm (003000) has a Net Asset Quality Index of 72.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩472.99 Billion minus total liabilities of ₩132.16 Billion yields net assets of ₩340.83 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Bukwang Pharm asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Bukwang Pharm Net Asset Quality Index Over Time (2007–2024)
This chart shows how Bukwang Pharm's Net Asset Quality Index has evolved across 14 annual periods from 2007 to 2024. As of September 2025, the index stands at 72.1%, representing net assets of ₩340.83 Billion against total assets of ₩472.99 Billion KRW. See Bukwang Pharm current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Bukwang Pharm (2007–2024)
The table below presents the year-by-year Net Asset Quality Index for Bukwang Pharm from 2007 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Bukwang Pharm worth.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 65.4% | ₩244.15 Billion | ₩373.18 Billion | ₩129.03 Billion | ▲ +10.8 pp |
| 2023 | 54.6% | ₩234.26 Billion | ₩429.02 Billion | ₩194.75 Billion | ▼ -13.2 pp |
| 2022 | 67.8% | ₩271.85 Billion | ₩400.93 Billion | ₩129.08 Billion | ▼ -2.7 pp |
| 2021 | 70.5% | ₩280.06 Billion | ₩397.42 Billion | ₩117.36 Billion | ▲ +2.8 pp |
| 2020 | 67.6% | ₩271.19 Billion | ₩400.97 Billion | ₩129.78 Billion | ▼ -16.4 pp |
| 2019 | 84.0% | ₩326.49 Billion | ₩388.53 Billion | ₩62.05 Billion | ▲ +0.3 pp |
| 2018 | 83.8% | ₩413.44 Billion | ₩493.62 Billion | ₩80.17 Billion | ▼ -5.7 pp |
| 2017 | 89.4% | ₩211.30 Billion | ₩236.23 Billion | ₩24.93 Billion | ▼ -0.9 pp |
| 2016 | 90.3% | ₩214.63 Billion | ₩237.63 Billion | ₩23.00 Billion | ▲ +1.6 pp |
| 2015 | 88.8% | ₩225.15 Billion | ₩253.66 Billion | ₩28.51 Billion | ▲ +0.1 pp |
| 2014 | 88.7% | ₩210.00 Billion | ₩236.82 Billion | ₩26.82 Billion | ▲ +0.6 pp |
| 2013 | 88.1% | ₩201.07 Billion | ₩228.21 Billion | ₩27.14 Billion | ▲ +12.6 pp |
| 2008 | 75.5% | ₩174.01 Billion | ₩230.55 Billion | ₩56.54 Billion | ▼ -3.9 pp |
| 2007 | 79.4% | ₩170.63 Billion | ₩215.02 Billion | ₩44.39 Billion | — |